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Summary
Impaired growth is often associatedwith an extension of lifespan.
However, the negative correlation between somatic growth and
life expectancy is only true within, but not between, species. This
can be observed because smaller species have, as a rule, a shorter
lifespan than larger species. In insects and worms, reduced
reproductive development and increased fat storage are associ-
ated with prolonged lifespan. However, in mammals the relation-
ship between the dynamics of reproductive development, fat
metabolism, growth rate, and lifespan are less clear. To address
this point, female transgenicmice thatwereoverexpressing similar
levels of either intact (D-mice) ormutant insulin-likegrowth factor-
bindingprotein-2 (IGFBP-2) lacking theArg-Gly-Asp (RGD)motif (E-
mice) were investigated. Both lines of transgenic mice exhibited a
similar degree of growth impairment (9% and10%) in compar-
ison with wild-type controls (C-mice). While in D-mice, sexual
maturation was found to be delayed and life expectancy was
significantly increased in comparison with C-mice, these parame-
terswere unaltered in E-mice in spite of their reduced growth rate.
These observations indicate that the RGD-domain has a major
influence on the pleiotropic effects of IGFBP-2 and suggest that
somatic growthand timeof sexualmaturity or somatic growthand
life expectancy are less closely related than thought previously.
Key words: growth; aging; reproductive development; cell
signaling; IGFBP-2; AKT.
Introduction
In laboratory animals, growth inhibition by targeted mutation of the
growth hormone or insulin-like growth factor receptors (GHR, IGF1R) is
known to significantly increase lifespan (Coschigano et al., 2003;
Holzenberger et al., 2003), suggesting that higher growth activities
may be at the expense of lifespan; this raises the question of whether
smaller body dimensions might result in a healthier condition (Bartke,
2012). In addition, in worms and insects, long-lived mutants with
impaired insulin/IGF-signaling frequently represent dwarf individuals
(Kenyon, 2005). Within a species, for example, in dog breeds, size is
negatively correlated with life expectancy, whereas between species, this
correlation is, as a rule, positive (Kraus et al., 2013). However,
phenotypic characteristics in long-lived and dwarf mutant mice fre-
quently have revealed reproductive deficits as well (Brown-Borg, 2009),
and experimental ablation of the reproductive system in nematodes has
been found to increase both growth and lifespan (Patel et al., 2002).
Consequently, there is an intriguing connection between somatic
growth, reproductive development and lifespan. Currently, the strength
of correlation between the different pleiotropic functions is unclear.
From the negative correlation between growth and life expectancy, it
may be assumed that blocking the trophic effects of GH or IGF1 could be
beneficial for healthy aging and an increased lifespan (Gallagher &
LeRoith, 2011). In fact, female Ghr knockout mice in a C57BL/6
background have been demonstrated to have a 21% increased lifespan
in comparison with wild-type mice (Coschigano et al., 2003). In a
different genetic background, Ghr/ mice were able to reach an age of
almost 5 years, which represents a quantum leap of lifespan extension
and is unmatched by other long-lived mouse models (Junnila et al.,
2013). Owing to mutations of the GHR in Laron dwarfs and corre-
sponding mouse mutants being associated with a drastic reduction of
growth, it was investigated whether moderate growth impairment, for
example, caused by overabundance of IGF1 inhibitory binding proteins
(Hoeflich et al., 2004), may still have significant consequences for life
expectancy and sexual development. Consequently, two different IGFBP-
2 transgenic mouse models (Hoeflich et al., 1999, 2002) overexpressing
either wild-type mouse IGFBP-2 (D-mice) or mutated IGFBP-2 lacking the
RGD-motif required for integrin binding (Pereira et al., 2004) and
carrying an RGE-sequence instead (E-mice) were investigated. Circulat-
ing IGF1 levels and IGFBP-2 transgene expression levels in different
tissues and compartments were similar in both transgenic lines, and this
was due to the fact that identical expression vectors were used for
generation of both mouse models (Hoeflich et al., 2002). The oncogenic
potential of IGFBP-2 for glioma progression is mediated by the RGD-
motif, integrin b1, and integrin-linked kinase and results in the activation
of the NF-jB network (Holmes et al., 2012). Also, in breast cancer,
IGFBP-2 exerts malignant potential, and again, this depends on the
RGD-motif but involves regulation of estrogen receptors as
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demonstrated by the Perks laboratory (Foulstone et al., 2013). In
addition, the RGD-domain has been discussed in a context with
metabolic functions of IGFBP-2 (Wheatcroft & Kearney, 2009). In fact,
by direct comparison of D- and E-mice, we were able to demonstrate
that the RGD-motif present in IGFBP-2 is involved in the regulation of
GLUT4 trafficking and glucose clearance after oral glucose administra-
tion (Reyer et al., 2015). The RGD-motif is distinct from the two IGF-
binding sites and both variants of IGFBP-2 bind IGF2 with high affinity as
demonstrated by Western ligand blotting (Hoeflich et al., 1999, 2002).
Here, our experimental system was used for testing other pleiotropic
functions of wild-type vs. mutant IGFBP-2 overabundance on somatic
growth, time of sexual maturity, and lifespan. In particular, the
hypotheses tested included i) moderate growth inhibition by IGFBP-2
can prolong life expectancy significantly; and ii) the RGD-sequence of
IGFBP-2 is a determinant of its pleiotropic effects. The results are
discussed with respect to the original antagonistic pleiotropy concept
(Williams, 1957) as well as to the more recent disposable soma theory of
aging (Kirkwood & Austad, 2000).
Results
The inhibitory effects of wild-type and RGD-deficient IGFBP-2 on somatic
growth observed at 10 weeks of age were also persistent in 30-week-
old female mice (Fig. 1). In both age groups, the weight reductions of
D-mice and E-mice in comparison with C-mice ranged between 8% and
13%. On a tissue level (Fig. 2), overexpression of wild-type IGFBP-2 in
female D-mice resulted in stronger weight reductions in skeletal muscles
than in the liver, heart, or brain, which is in accordance with previous
results (Hoeflich et al., 1999). At 10 weeks of age, the effects of
RGD-deficient IGFBP-2 in E-mice were comparable to those in D-mice for
body weight and weights of isolated muscle, liver, heart, perinephric,
brown fat, and gonadal fat. At 10 weeks of age, the negative effect of
IGFBP-2 on the brain weight observed in D-mice was not reproduced in
E-mice. Perinephric fat mass was particularly sensitive to the inhibitory
effects of wild-type IGFBP-2 overexpression. At an age of 30 weeks, the
effects of wild-type and mutant IGFBP-2 overexpression were signifi-
cantly different. The absolute weight data and pairwise comparisons for
both age groups are provided as Tables S1–S4. As identified by three
independent studies in three different mouse facilities including 78
transgenic mice and 63 controls (Fig. 3A), overexpression of wild-type
IGFBP-2 resulted in a significant increase of long-term survival in female
D-mice (P < 0.05). The beneficial effects of elevated IGFBP-2 expression
for maximal life length were observed in C57BL/6 (study I and III) and in
mice of a mixed genetic background (50% C57BL/6, 50% NMRI; study
II). Consequently, this increase is not restricted to one defined inbred
strain but is also present in a more complex genetic background. While
growth restrictions were also present in male mice, ranging between
9% and 11% (Tables S2 and S4), in contrast to their female
counterparts, male D-mice and E-mice had no increase in lifespan
compared to sex-matched C-mice (Fig. 3B). In addition, progressive
survival was higher (P = 0.002) in female but not in male D-mice
(Fig. 4). While at an age of 831 days, 31% of all female D-mice were
still alive, less than 6% of nontransgenic littermates had survived.
However, the effects of IGFBP-2 on lifespan were dependent on the
presence of the RGD-sequence in IGFBP-2 because in E-mice, no life-
prolonging effect was observed (study IV; lifespan E-mice:
765  34 days, n = 19; lifespan C-mice: 750  37 days, n = 33). It
was next considered if reproductive development was altered in D- or
E-mice. In fact, female D- but not E-mice were characterized by
significantly delayed sexual maturity (Fig. 5). While in control mice, age
at first estrus was 36.1  1.1 days, D-mice reached an age of
42.9  1.8 days before they came into their first estrus. By contrast, a
delay of reproductive development was not found in E-mice (E-mice;
37.0  1.7 days). Age at vaginal opening was unaffected by the
genotype. At an age of 10 weeks phosphorylation of Ser473 present in
AKT was specifically increased in female brain lysates (Fig. 6) but not in
liver, fat, or muscle tissues (data not shown) from D-mice compared to
E-mice and controls.
Discussion
In this study, the pleiotropic effects of intact and RGD-deficient IGFBP-2
were investigated in transgenic mice. Whether the RGD-motif present in
IGFBP-2 is relevant for growth, reproductive development and lifespan
were considered. In particular, the strength of correlation between
impaired somatic growth and improved long-term survival observed was
assessed in a number of mouse models characterized by growth
inhibition (Junnila et al., 2013).
Mild growth restrictions were found in mice overexpressing wild-type
or mutant IGFBP-2 lacking the RGD-motif. These findings are consistent
with previous results (Hoeflich et al., 1999, 2002) and support the
hypothesis that the RGD-motif is not required for the negative effects of
IGFBP-2 on somatic growth. We have shown previously that IGFBP-2 also
is a potent inhibitor of bone mass and bone lengths (Eckstein et al.,
2002) thus somatic growth inhibition is found both for body mass and
skeletal parameters. On a tissue level, it was found that the RGD-
sequence is of relevance in the brain and in perinephric fat, which can be
observed because age-specific effects in D- versus E-mice have been
observed in these tissues. The weight effects of IGFBP-2 overexpression
in other peripheral fat depots were not very well reproduced, particularly
in 30-week E-mice. Consequently, it is necessary to assume that there
are age- and tissue-dependent effects of the RGD-domain present in
IGFBP-2 for the control of fat accretion. At younger ages, overexpression
of mouse IGFBP-2 increased gonadal fat mass (Rehfeldt et al., 2010),
whereas overexpression of human IGFBP-2 in mice blocked the
development of age-related obesity later in life (Wheatcroft et al.,
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Fig. 1 Body weights of female mice expressing wild-type (D-mice) or mutated
IGFBP-2 (E-mice), and of nontransgenic controls (C-mice) at two different ages (10
and30 weeks). Both intact andmutated IGFBP-2 exerted negative effects on somatic
growth in 10- and 30-week-old female mice. Different superscripts indicate
significant differences (P < 0.05). Data are presented as LSM  SE (n > 14).
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instead, these results indicate differential effects of mouse IGFBP-2 in
perinephric and other fat tissues. Currently, a role of two distinct
heparin-binding domains present in IGFBP-2 has been suggested for
adipocyte differentiation (Xi et al., 2013), and the RGD-motif has not
been considered as an effector of fat metabolism.
In general, the female C-mice investigated in this study had a shorter
lifespan when compared with male C-mice, which is in line with previous
results in C57BL/6 mice (Turturro et al., 1999). Growth inhibition in
females but not in males correlated with improved long-term survival in
D-mice. A sexually dimorphic effect on lifespan has also been described
in heterozygous Igf1r knockout mice (Holzenberger et al., 2003) and fits
with the concept that reduced IGF1 signaling affects lifespan, particularly
in female mice, whereas impaired GH signaling increases lifespan in both
sexes (Bartke, 2011; Junnila et al., 2013). In this study, antagonistic
pleiotropy (Bartke, 2011), which describes beneficial and adverse effects
of a hormone during ontogeny, was only observed in female D-mice.
Surprisingly, growth inhibition in female E-mice was not associated with
an increase in lifespan, as noted in female D-mice. Consequently, loss of
the RGD-motif loosened the negative correlation between growth and
lifespan.
Between species, early reproductive development is associated with a
shorter lifespan (Harvey & Zammuto, 1985). Consequently, this study
considered if reproductive development was altered in D- or
E-mice. Female D- but not E-mice required significantly more time than
C-mice for reproductive development, which was measured as the age at
first estrus. Preliminary data further indicate significant reductions of ovary
weights in D- but not in E-mice at an age of 10 weeks (data not shown).
Therefore, the findings in this study support the idea of a link between
lifespan and reproductive development. Ablation of the reproductive
system inwormsor insects has beendemonstrated toextend lifespan (Rose
& Charlesworth, 1980; Hsin & Kenyon, 1999) supporting the disposable
soma theory of aging, which reflects the functional interrelationships
between the reproductive system and other cells or tissues (Kirkwood &
Austad, 2000). One central assumption of that theory is that energetic
input in nonreproductive tissues has to be at the expense of cells required
for reproduction and vice versa owing to a certain limitation of resources.




















































































































































































































Fig. 2 Organ weights of female mice
expressing wild-type (D-mice) or mutated
IGFBP-2 (E-mice), and of nontransgenic
controls (C-mice) at two different ages
(10 and 30 weeks). Weight changes in
transgenic mice are expressed as a percent
increase or decrease in comparison with C-
mice, respectively (n > 14). Absolute values
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Fig. 3 Life expectancy of female (A) and male (B) transgenic mice overexpressing
wild-type IGFBP-2 (D-mice) or IGFBP-2 lacking the RGD-sequence (E-mice)
compared to wild-type controls (C). In three different locations and in the presence
of different genetic backgrounds after an age of 490 days, female D-mice were
characterized by increased life expectancy compared with wild-type littermates (nc:
study I: 22, study II: 40, study III: 17; ntg: study I: 20, study II: 35, study III: 9). In
study IV, female E-mice (n = 19) were characterized by a similar long-term survival
in comparison with nontransgenic littermates (n = 16). Males: nc: study II: 17,
study III: 20, study IV: 18; ntg: study II: 15, study III: 25, study IV: 16; data are
presented as LSM  SE; *P < 0.05.
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growth-restricted animals, it does not explain the lack of lifespan effects in
growth-restricted E-mice observed in the present study. By contrast, these
findings are not contradictory to themore general concept of antagonistic
pleiotropy (Williams, 1957) according to which, specific factors may have
beneficial and detrimental effects depending on the period of time.
However, delayed reproductive development may also correlate with
somatic overgrowth in mice overexpressing LIN28B (Zhu et al., 2010),
pointingto thefact that theconnectionsbetweengrowthandreproductive
development may not be unidirectional. Both somatic growth and
reproductive development do represent early events in individual
ontogeny. However, both events have differential dynamics in D-, E-, and
C-mice. This implicates, at least to some extent, that an uncoupling of
pleiotropic IGFBP-2 effects is possible in the current experimental system.
The concept of antagonistic pleiotropy has been discussed extensively in
the context of the GH/IGF-system before (Bartke, 2011).
In addition, it is also necessary to consider particular current concepts
of an interrelation between lifespan, reproduction, and fat metabolism
(Hansen et al., 2013). It is well established that estradiol signaling is
centrally connected with reproduction and energy metabolism (Sinchak
& Wagner, 2012). In that context, it is of particular interest that
overexpression of the IGFBP-2 variant inversed the effects of wild-type
IGFBP-2 in peripheral fat pads in mice. Consequently, the system in this
study supports the idea of a connection between fat metabolism,
reproductive development, and life expectancy. Foulstone and cowork-
ers found that IGFBP-2 controls estrogen receptor alpha expression in
breast cancer cells (Foulstone et al., 2013). Thus, the dynamics of
reproductive development may represent a determinant of lifespan, as
originally observed by interspecies comparisons and after correction for
body weight as a confounding factor (Harvey & Zammuto, 1985). In
addition, in mutant laboratory mouse strains, delayed maturation was
associated with higher lifespan (Brown-Borg, 2009). However, all models
had reduced body dimensions in common. Here, it was demonstrated
that lifelong reduction of somatic growth is not sufficient to increase the
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Fig. 5 Reproductive development in
female D- and E-mice in comparison with
controls. Plugs and vaginal smears were
inspected at daily intervals and body
weights were recorded. Data are presented
as LSM  SE (C-mice: n = 45; D-mice
n = 17; E-mice: n = 17). Different
superscripts indicate significant differences




























































Fig. 4 Progressive survival in female
transgenic mice overexpressing wild-type
IGFBP-2 (D-mice) and in mice
overexpressing IGFBP-2 lacking the RGD-
sequence (E-mice). Progressive survival was
monitored in male and female D- and
E-mice versus controls from all locations
included in the present study. Female
D-mice had increased survival (P = 0.002)
in comparison with female C- mice: n = 71,
respectively; male D- and C- mice: n = 41;
female E-mice and C-mice: n = 16/19; male
E- and C-mice: n = 19/16 (B6: C57BL/6).
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reproductive development, energy metabolism, and lifespan, which have
already been demonstrated in worms and flies (Gerisch et al., 2001; Flatt
et al., 2008). Imaginal morphogenesis protein-late 2 (IMP-L2), a protein
homologous to MAC25 (IGFBP7) that binds to insulin in Drosophila, has
also been demonstrated to increase lifespan (Honegger et al., 2008; Alic
et al., 2011), and it was discussed that IGFBPs may play a role in
mammalian aging. Furthermore, IMP-L2 is increased in germline-less flies
(Flatt et al., 2008), which may be connected with improved longevity
and thus suggests that insulin- or the IGF-binding protein may have
conserved functions during evolution.
It is of particular interest that genetic linkage of female reproductive
development and lifespan has been suggested to be mediated by IGF1 in
inbred mouse lines (Yuan et al., 2012). In this work, evidence is provided
for the coupling of pleiotropic functions of IGFBP-2 beingmediated by the
RGD-motif, which is primarily considered to be IGF-independent
(Wheatcroft & Kearney, 2009). However, coupling of reproductive
development and lifespan has been clearly demonstrated in Caenorhab-
ditis elegans (Dillin et al., 2002). Thus, while this study demonstrates
uncoupling of somatic growth and the control of lifespan, it does not
exclude the possibility that, in other models, functional coupling of both
parameters may occur. In addition, we cannot exclude that in a condition
of stronger body weight reduction functional coupling of somatic growth
and lifespanmay be observed.Concerning the control of circulating versus
local IGF-activity, wemay speculate that local effects of IGF1may bemore
important than endocrine effects at least in our experimental system, as
both IGFBP-2 variants bind the IGFs with high affinity, whereas tissue-
specific affects are different due to the presence or absence of integrin
binding via the RGD-motif. Our results further support a functional
relevance of the RGD-motif for activation of AKT in female brains.
In summary, it was demonstrated that growth inhibition per se does
not increase the lifespan. In terms of pleiotropy, this study provides
evidence that isolated functions of IGFBP-2 rely on the presence of the
RGD-motif present in IGFBP-2. These functions include reproductive
development, accretion of fat mass, and long-term survival. While these
results are not superimposable with the disposable soma theory of
aging, the concept of antagonistic pleiotropy may integrate with the
results. Accordingly, reproductive development and energy metabolism,




All animal experiments were performed in accordance with the German
Animal Welfare Act with permission from the respective animal welfare
authorities. Mice were kept in standard cages and had access to pelleted
food (studies I and II: V1534, Ssniff, Soest, Germany; studies III and IV:
Altromin 1314, Altromin, Lage, Germany) and water ad libitum. For
studying long-term survival, mice older than 490 days were used. In
study I, male and female hemizygous IGFBP-2 transgenic mice and
controls (C57BL/6) as described in (Hoeflich et al., 1999) were kept at
the Gene Center, LMU Munich. In study II, IGFBP-2 transgenic mice and
controls were used from a mixed genetic background (C57BL/6 9 NMRI)
(Hoeflich et al., 2001) and were maintained in the mouse facility of the
Institute of Veterinary Pathology (LMU Munich). Studies III and IV were
performed under semi-barrier conditions in the mouse facility of the
Leibniz Institute of Farm Animal Biology (FBN) in Dummerstorf, Germany.
In both studies, transgenic C57BL/6 mice overexpressing either wild-type
IGFBP-2 containing the intact RGD-sequence (D-mice; study III) or
mutant IGFBP-2 (E-mice; study IV) lacking the RGD-sequence motif
(Hoeflich et al., 2002) were used. If senescent mice were suffering from
severe illness or had any other signs of distress, they were euthanized.
For the determination of sexual maturity, vaginal smears were stained
with hematoxylin and eosin before being visualized under a microscope
at daily intervals. The initial presence of cornified vaginal epithelial cells
lacking nuclear staining was considered as the day of first estrus (Allen,
1922). At an age of 10 and 30 weeks, mice were euthanized by cervical
dislocation, organs were dissected, and their weights were recorded.
Analysis of signal transduction was performed as recently described
(Reyer et al., 2015).
Statistical analysis
The data analysis was performed using SAS software, version 9.4 for
Windows (Copyright, SAS Institute Inc., Cary, NC, USA). Descriptive
statistics and tests for normality were carried out using the UNIVARIATE
procedure of Base SAS software. Data that could be considered as






























































Fig. 6 Specific activation of AKT in brain lysates from female D-mice in comparison with E-mice and controls at an age of 10 weeks. Data are presented as % of
control  SE n = 10; *P < 0.05; **P < 0.01; ***P < 0.001.
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MIXED procedure of SAS/STAT software. The ANOVA model for the
body and organ weight data contained the fixed factors genotype
(levels: C, D, and E), age (levels: 10, 30 weeks) and sex (levels: male,
female), and all interactions between the fixed factors.
The lifespan data were analyzed by one-way ANOVA using models
with the factors transgene (levels: C, D, or levels: C, E) for each
genotype, line, study, and sex (c.f. studies I–IV). In these analyses, only
animals with a minimum age of 490 days were considered. In addition,
the survivor functions were estimated and compared with the LIFETEST
procedure of SAS/STAT software and the Mantel-Cox test (GraphPad
Prism software, GraphPad, la Jolla, CA, USA). A one-way model with the
factor genotype (levels: C, D, E) was applied for the maturation data.
Least-square means (LSM) and their standard errors (SE) were computed
for each fixed effect in the ANOVA models, and all pairwise differences
of LSM were tested for significance using the Tukey–Kramer procedure.
Effects and differences were considered significant if P < 0.05.
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